Tumor-targeting vaccination instructs graft-vs.-tumor immune responses

OncoImmunology

Volumn 2, Issue 10, 2013, Pages

  Manzo, Teresa ^a,b   Michelini, Rodrigo Hess ^a   Sturmheit, Tabea ^a,b   Basso, Veronica ^a   Bellone, Matteo ^a   Mondino, Anna ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Immunotherapy; Minor histocompatibility antigens; T cells; Transplantation; Tumor; Vaccination

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER IMMUNOTHERAPY; CD3+ T LYMPHOCYTE; DONOR LYMPHOCYTE INFUSION; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS TUMOR IMMUNE RESPONSE; HLA MATCHING; IMMUNE RESPONSE; LONG TERM SURVIVAL; LYMPHOCYTIC INFILTRATION; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PROSTATE ADENOCARCINOMA; TUMOR REJECTION;

EID: 84890277189     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.25996     Document Type: Article

References (10)

1. Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112:4371-83; PMID:19029455; http://dx.doi. org/10.1182/blood-2008-03-077974
2. Turcotte S, Rosenberg SA. Immunotherapy for metastatic solid cancers. Adv Surg 2011; 45:341-60; PMID:21954698; http://dx.doi.org/10.1016/j. yasu.2011.04.003
3. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995; 92:3439- 43; PMID:7724580; http://dx.doi.org/10.1073/ pnas.92.8.3439
4. Degl'Innocenti E, Grioni M, Boni A, Camporeale A, Bertilaccio MT, Freschi M, Monno A, Arcelloni C, Greenberg NM, Bellone M. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization. Eur J Immunol 2005; 35:66- 75; PMID:15597325; http://dx.doi.org/10.1002/ eji.200425531
5. Granziero L, Krajewski S, Farness P, Yuan L, Courtney MK, Jackson MR, Peterson PA, Vitiello A. Adoptive immunotherapy prevents prostate cancer in a transgenic animal model. Eur J Immunol 1999; 29:1127-38; PMID:10229079; http://dx.doi.org/10.1002/ (SICI)1521-4141(199904)29 :041127: :AIDIMMU1127 3.0.CO;2-X
6. de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN. TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. J Immunol 2008; 181:2563-71; PMID:18684947
7. Hess Michelini R, Manzo T, Sturmheit T, Basso V, Rocchi M, Freschi M, Listopad J, Blankenstein T, Bellone M, Mondino A. Vaccine-instructed intratumoral IFN-gamma enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation. Cancer Res 2013; 73:4641-52; PMID:23749644; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3464
8. Rezvani K. Posttransplantation vaccination: concepts today and on the horizon. Hematology Am Soc Hematol Educ Program 2011:299-304; http://dx.doi. org/10.1182/asheducation-2011.1.299.
9. Manzo T, Hess Michelini R, Basso V, Ricupito A, Chai JG, Simpson E, Bellone M, Mondino A. Concurrent allorecognition has a limited impact on posttransplant vaccination. J Immunol 2011; 186:1361-8; PMID: 21209285; http://dx.doi.org/ 10.4049/jimmunol.1002030.
10. Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. J Immunol 2013; 190:1351- 9; PMID:23275602; http://dx.doi.org/10.4049/ jimmunol.1200391